Neuronetics与Ant Neuro达成战略合作,将神经导航技术融入Neurostar TMS治疗

美股速递
May 14

Neuronetics Inc.与Ant Neuro宣布建立战略合作关系,旨在将先进的神经导航系统整合至Neurostar经颅磁刺激治疗平台中。这一合作标志着脑刺激疗法精准化迈出了关键一步,有望通过实时影像引导提升治疗靶向性与疗效一致性。

双方计划结合各自在神经调控设备与神经导航软件领域的专长,共同开发集成解决方案。该方案预期能为临床医生提供更直观、更精确的刺激定位工具,从而优化治疗流程,并为患者带来更为个体化的治疗体验。

此次合作不仅将强化Neurostar TMS系统在精神神经疾病治疗领域的竞争力,也可能为未来脑科学研究和临床应用的深度融合开辟新路径。随着精准医疗需求的持续增长,技术整合已成为推动神经治疗领域创新的重要驱动力。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10